Biomerica Inc 's ability to collect accounts receivable sequentially worsen to 2.72, pointing to a challenging and on top of that deteriorating business climate for the In Vitro & In Vivo Diagnostic Substances industry. Biomerica Inc 's Accounts Receivable average collection period in the Aug 31 2026 quarter, has increased to 134 days, from 118 days, in the May 31 2026 quarter.

If we take a look into Healthcare sector 363 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Aug 31 2026 from 1456 to 2657.

What is Receivable Turnover Ratio?
What is Biomerica Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BMRA Receivables Turnover Ratio	(Aug 31 2026) I. Quarter	(May 31 2026) IV. Quarter	(Feb 28 2026) III. Quarter	(Nov 30 2025) II. Quarter	(Aug 31 2025) I. Quarter
Y / Y Receivable Change	52.28 %	119.97 %	-25.79 %	-25.72 %	-22.31 %
Y / Y Revenue Change	-8.33 %	16.96 %	-11.8 %	-26.04 %	-23.63 %
Receivable Turnover Ratio (TTM)	2.72	3.1	3.56	3.43	3.32
BMRA's Total Ranking	# 2657	# 1456	# 113	# 1387	# 315
Accounts Receivable average collection period days	134	118	103	106	110
Seq. Receivable Change	14.12 %	70.88 %	-52.71 %	65.15 %	64.84 %
Seq. Revenue Change	44.41 %	-11.25 %	-18.43 %	-12.32 %	84.25 %

Receivable Turnover Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 9
Healthcare Sector	# 364
Overall Market	# 2657

Receivable Turnover Ratio Statistics
High	Average	Low
18.15	6.16	4.22
(May 31 2022)		(Nov 30 2020)

BMRA Company Profile • Back to BMRA Efficiency Comparisons • Compare BMRA Receivables Turnover Ratio to its Competitors

Financial Statements
Biomerica Inc 's Accounts Receivable	$ 2 Millions	Visit BMRA's Balance sheet
Biomerica Inc 's Sales TTM	$ 4 Millions	Visit BMRA's Income Statement
Sources of BMRA's Revenues		Visit BMRA's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BMRA's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BMRA's Growth Rates	BMRA's Roa	BMRA's Inventory Turnover Ratio	BMRA's Dividend Comparisons
BMRA's Profitability Ratios	BMRA's Roi	BMRA's Asset Turnover Ratio	BMRA's Dividend Growth
BMRA's Valuation Ratios	BMRA's Roe	BMRA's Financial Strength Ratios	BMRA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Aug 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Aug 31 2026	Receivable at quarter ending Aug 31 2026
Haemonetics Corporation	6.48	$ 1,382.737 Millions	$ 213.396 Millions
Zevra Therapeutics Inc	6.40	$ 140.548 Millions	$ 21.947 Millions
Bruker Corporation	6.39	$ 3,512.500 Millions	$ 549.350 Millions
Labcorp Holdings Inc	6.38	$ 14,594.500 Millions	$ 2,286.925 Millions
Bionano Genomics Inc	6.36	$ 31.085 Millions	$ 4.888 Millions
Healthcare Services Group Inc	6.36	$ 1,879.860 Millions	$ 295.784 Millions
Intellia Therapeutics Inc	6.33	$ 52.887 Millions	$ 8.355 Millions
Gilead Sciences Inc	6.29	$ 30,988.000 Millions	$ 4,929.000 Millions
Integra Lifesciences Holdings Corp	6.26	$ 1,656.786 Millions	$ 264.861 Millions
Atara Biotherapeutics Inc	6.23	$ 4.019 Millions	$ 0.645 Millions
Orthofix Medical Inc	6.18	$ 835.683 Millions	$ 135.265 Millions
Neogen Corporation	6.17	$ 884.120 Millions	$ 143.371 Millions
Vertex Pharmaceuticals Inc	6.10	$ 12,951.600 Millions	$ 2,123.550 Millions
Mimedx Group Inc	6.06	$ 303.363 Millions	$ 50.077 Millions
Harvard Bioscience Inc	6.02	$ 90.339 Millions	$ 15.007 Millions
Rxsight Inc	6.00	$ 122.088 Millions	$ 20.336 Millions
Zai Lab Limited	5.99	$ 441.727 Millions	$ 73.769 Millions
Avantor Inc	5.98	$ 6,635.600 Millions	$ 1,110.300 Millions
Msa Safety Inc	5.96	$ 2,015.730 Millions	$ 338.388 Millions
Bio rad Laboratories Inc	5.92	$ 2,593.000 Millions	$ 437.800 Millions
Illumina Inc	5.87	$ 4,538.000 Millions	$ 773.500 Millions
Resmed Inc	5.82	$ 5,743.164 Millions	$ 986.765 Millions
Maxcyte inc	5.80	$ 34.374 Millions	$ 5.931 Millions
Conmed Corporation	5.76	$ 1,369.288 Millions	$ 237.544 Millions
Exagen Inc	5.76	$ 72.769 Millions	$ 12.629 Millions
Clearpoint Neuro Inc	5.75	$ 45.493 Millions	$ 7.906 Millions
Davita Inc	5.75	$ 14,167.545 Millions	$ 2,462.529 Millions
Elutia Inc	5.75	$ 9.637 Millions	$ 1.676 Millions
Abbott Laboratories	5.71	$ 48,229.000 Millions	$ 8,442.500 Millions
Strata Critical Medical Inc	5.71	$ 236.425 Millions	$ 41.435 Millions

Date modified: 2026-10-16T04:51:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.